FDA published comparative performance data for COVID-19 molecular diagnostic tests
On Sept. 15, 2020, the FDA published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The tables show the Limit of Detection (LoD) of more than 55 authorized molecular diagnostic COVID-19 tests against a standardized sample panel provided by the FDA.
Tags:
Source: U.S. Food and Drug Administration
Credit: